GVP Module VI - Collection, management and submission of reports of suspected ADR to Medicinal Products
OBJECTIVES
The purpose of this training is to enable you to better understand the new obligations of Marketing Authorisation Holder's (MAH's) on collection, management and submission of reports of suspected Adverse Reactions to Medicinal Products as described in GVP Module VI rev. 2 effective since 22nd of November 2017.
MAH, Risk Management System, European GVP Module VI, Reporting of ADR, Emerging Safety Issue, Post-authorisation studies
LEARNING OUTCOMES
Once completed, you will be able to:
Know all new definitions
Identify and notify an emerging safety issue
Comply strictly with the new requirements for collecting and reporting adverse reactions in the interim and final arrangements
Be aware of new changes including in the Revision 2, particularly for the ICSRs
This short course has been added to your Study List: GVP Module VI - Collection, management and submission of reports of suspected ADR to Medicinal Products
Please note that this short course is currently in update.
It will be available within 15 working days.
This short course has been added to your Study List: GVP Module VI - Collection, management and submission of reports of suspected ADR to Medicinal Products
LOG IN OR SIGN UP TO "MY Eu2P"
